SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Processing

Read more breaking news

 

 
News in brief

Teva makes first Indian forray with help of P&G

By Natalie Morrison , 26-Jul-2012
Last updated on 26-Jul-2012 at 13:29 GMT

Teva Pharmaceuticals and P&G to do manufacturing in India

Teva Pharmaceuticals is set to build its first Indian production plant after finalising a pact with healthcare giant Procter & Gamble (P&G), according to local authorities.

Together the firms will reportedly invest more than $89m (Rs 5bn) in an OTC (over-the-counter) factory at Sanand, Gujarat. They are said to have already secured a 15 acre plot of land for the construction.

According to the Times of India the joint venture will use the facility to make inhalers, throat drops and cough syrups for the Vicks brand.

Gujarat's Commissioner Food and Drug Control Administration (FDCA) H G Kohsia said the plant would eventually hire up to 1,000 people when fully operational.

He said that a four member delegation led by Teva's VP of corporate quality, Karin Baer, has already met with authorities seeking “details of setting up a facility to manufacture OTC  products like cough syrups, inhalers amongst others.” 

According to the Economic Times, Kohsia believes a formal announcement will be made after finalising plans with the Government at the Vibrant Gujarat Global Summit-2013 in January.

When in-PharmaTechnologist.com contacted Teva to confirm whether the claims were true they declined to respond "at this time."

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry